Group 1 - The company plans to use part of the raised funds to increase capital in its wholly-owned subsidiary, Beijing Aojing Medical Equipment Co., Ltd., for the implementation of fundraising projects [1][2] - The total amount of funds raised is approximately RMB 547.67 million, with a net amount of RMB 500.82 million after deducting issuance costs [1][2] - The capital increase will amount to RMB 9.77 million, raising the registered capital of Beijing Aojing Medical Equipment from RMB 39.00 million to RMB 48.77 million, maintaining 100% ownership [2][3] Group 2 - The fundraising projects include the development of guided bone regeneration membranes, artificial bone powder, and mineralized collagen artificial bone repair materials targeted at the U.S. market [2] - The company has established a dedicated account for the raised funds and will implement strict regulatory measures to ensure the safety of the funds [5][6] - The board of directors and the supervisory board have approved the capital increase, which does not require shareholder meeting approval, and complies with relevant regulations [6]

Fundraising Overview - The company raised a total of RMB 547,666,677.62 through the issuance of 33,333,334 shares at a price of RMB 16.43 per share, with a net amount of RMB 500,816,913.05 after deducting issuance costs [1][2] - The funds were verified by an accounting firm and were deposited into a dedicated bank account [1] Fund Management - The company and its subsidiaries have opened dedicated fundraising accounts at various banks to ensure proper management and usage of the raised funds [2] - Agreements have been signed with banks to regulate the management of these funds [2][3] Account Closure - The company has closed a specific fundraising account at Industrial Bank Co., Ltd. due to adjustments in the project implementation [4] - The closure of this account has led to the termination of the corresponding four-party supervision agreement [4]